ORIG3N is a biotech company based in Boston, MA and focused on regenerative medicine and personalized health. We are leading a transformation in the understanding and treatment of rare, genetically inherited diseases. Our science is based on Nobel Prize-winning regenerative medicine technology, and our approach will replace the trial-and-error guesswork of diagnosing and treating disease. We’ve established the world’s largest uniformly consented cell repository to better understand the cellular and molecular foundations of disease. The cells are ever-renewing and give rise to a living database of humanity we call LifeCapsule.